Recently, Kenvue reported a 1.2% year-over-year decline in organic sales for the first quarter of 2025, reflecting a challenging external environment shaped by ongoing global headwinds, including the gross impact of current tariffs. Its net sales recorded $3.7 billion.
Despite this pressure, company officials emphasized resilience and agility in navigating these dynamics. For the full year, Kenvue expects a slight contraction in adjusted operating margin and projects adjusted diluted earnings per share (EPS) to remain roughly flat compared to 2024.
Across all three business segments, consumption outpaced organic sales, signaling underlying brand strength and consumer demand. This trend was supported by increased innovation and effective marketing activations, fueled by more competitive investment levels.
In Skin Health & Beauty, the net sales recorded $1 billion organic sales declined by 4.8% year-over-year. This drop was attributed to strategic investment decisions, a loss of product rotations in the U.S. club channel, inventory destocking in China, and a weak sun season in Latin America. However, in the EMEA region, organic sales continued to grow for the 12th consecutive quarter, supported by strategic pricing and breakthrough marketing campaigns.
Neutrogena remained a standout performer, holding its number one position in the U.S. by both value and volume for the second consecutive quarter. The brand also recorded a 30 basis point increase in household penetration among Gen Z consumers, driven by refreshed brand positioning and impactful social media campaigns.
In leadership news, Kenvue announced the appointment of Amit Banati as Chief Financial Officer, effective May 12. With three decades of experience in global consumer goods finance and operations, Banati will lead the company’s finance and strategy teams as Kenvue continues to focus on delivering profitable growth and long-term shareholder value.
